"Viral Hepatitis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any vaccine raised against any virus or viral derivative that causes hepatitis.
| Descriptor ID |
D014761
|
| MeSH Number(s) |
D20.215.894.899.955
|
| Concept/Terms |
Viral Hepatitis Vaccines- Viral Hepatitis Vaccines
- Hepatitis Vaccines, Viral
- Vaccines, Viral Hepatitis
- Hepatitis, Viral, Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Viral Hepatitis Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Viral Hepatitis Vaccines".
This graph shows the total number of publications written about "Viral Hepatitis Vaccines" by people in this website by year, and whether "Viral Hepatitis Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 2 | 8 | 10 |
| 2018 | 8 | 5 | 13 |
| 2019 | 6 | 3 | 9 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Hepatitis Vaccines" by people in Profiles.
-
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations. Sci Rep. 2021 02 26; 11(1):4741.
-
Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity. Lancet Gastroenterol Hepatol. 2020 09; 5(9):789.
-
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1. J Virol. 2019 11 15; 93(22).
-
Small Animal Models of Hepatitis E Virus Infection. Cold Spring Harb Perspect Med. 2019 08 01; 9(8).
-
Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control. Vaccine. 2019 10 08; 37(43):6566-6572.
-
Hepatitis B virus prevalence and risk factors in hard-to-reach Turkish population living in Belgium: A protocol for screening. Medicine (Baltimore). 2019 May; 98(18):e15412.
-
[Hepatitis C: From Individual Cure to Worldwide Elimination?] Dtsch Med Wochenschr. 2019 04; 144(8):535-542.
-
Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A. Antiviral Res. 2019 04; 164:154-161.
-
Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance. J Hepatol. 2019 07; 71(1):14-24.
-
Hepatitis C: Is eradication possible? Liver Int. 2019 03; 39(3):416-426.